Zevra Therapeutics, Inc.
ZVRA • NASDAQ • Stock Fundamentals
Zevra Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Neil F. McFarlane, with a market cap of $766.7M.
Market Cap$766.7M
Employees69.0
CEONeil F. McFarlane
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 6, 2026 · 1 month 8 days agoQ1 2026
View reportNext EarningsAug 11, 2026 · in 2 monthsAfter Market Close · Q2 2026
Financials
Based on Q1 2026 filing
Zevra Therapeutics, Inc. FAQ
Common questions about Zevra Therapeutics, Inc.
Zevra Therapeutics, Inc. (ZVRA) has a market capitalization of $766.7M and trades on NASDAQ.
Zevra Therapeutics, Inc. has approximately 69 employees.